Abstract
Background: It was previously shown that inactivation of gamma-synuclein which is a small soluble neuronal protein affects psycho-emotional status and cognitive abilities in knock-out mice.
Objective: Determine the role of gamma-synuclein inactivation on memory performance in aging animals.
Method: We used the passive avoidance test and acute amphetamine administration in aging gammasynuclein knock-out mice.
Results: As a result, we found moderate aging-unlinked deficit of dopaminergic neurotransmitter system of gamma-synuclein knock-out mice. At the same time, the evidence of progressive synaptic vesicle trafficking machinery impairment was obtained.
Conclusion: Therefore most likely these dysfunctions are associated with a reduction in the highefficient learning performance in tests that require intact working memory.
Keywords: Gamma-synuclein, working memory, passive-avoidance test, and amphetamine induced locomotion, soluble proteins, neural tissue.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:The Dopaminergic Dysfunction and Altered Working Memory Performance of Aging Mice Lacking Gamma-synuclein Gene
Volume: 17 Issue: 8
Author(s): Viktor S. Kokhan, Tat`yana G. Kokhan, Anna N. Samsonova, Vladimir P. Fisenko, Aleksey A. Ustyugov and Gjumrakch Aliev*
Affiliation:
- Institute of Physiologically Active Compounds RAS, Chernogolovka,Russian Federation
Keywords: Gamma-synuclein, working memory, passive-avoidance test, and amphetamine induced locomotion, soluble proteins, neural tissue.
Abstract: Background: It was previously shown that inactivation of gamma-synuclein which is a small soluble neuronal protein affects psycho-emotional status and cognitive abilities in knock-out mice.
Objective: Determine the role of gamma-synuclein inactivation on memory performance in aging animals.
Method: We used the passive avoidance test and acute amphetamine administration in aging gammasynuclein knock-out mice.
Results: As a result, we found moderate aging-unlinked deficit of dopaminergic neurotransmitter system of gamma-synuclein knock-out mice. At the same time, the evidence of progressive synaptic vesicle trafficking machinery impairment was obtained.
Conclusion: Therefore most likely these dysfunctions are associated with a reduction in the highefficient learning performance in tests that require intact working memory.
Export Options
About this article
Cite this article as:
Kokhan S. Viktor , Kokhan G. Tat`yana, Samsonova N. Anna , Fisenko P. Vladimir , Ustyugov A. Aleksey and Aliev Gjumrakch *, The Dopaminergic Dysfunction and Altered Working Memory Performance of Aging Mice Lacking Gamma-synuclein Gene, CNS & Neurological Disorders - Drug Targets 2018; 17 (8) . https://dx.doi.org/10.2174/1871527317666180726095734
DOI https://dx.doi.org/10.2174/1871527317666180726095734 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimers Disease
Current Alzheimer Research New Insights in Drug-Induced Mitochondrial Toxicity
Current Pharmaceutical Design Subject Index To Volume 2
Current Rheumatology Reviews Evaluation of the Ability of an Organic Derivative of Ruthenium(II) to Reinforce the Cytotoxicity of Fast Neutron Against Malignant Cells in Culture
Letters in Drug Design & Discovery Glioma Therapy: A Novel Insight in the Immunotherapeutic Regime with T11TS/SLFA-3
Central Nervous System Agents in Medicinal Chemistry The Parietal Atrophy Score on Brain Magnetic Resonance Imaging is a Reliable Visual Scale
Current Alzheimer Research Nanoneuromedicines for Neurodegenerative Diseases
Nanoscience & Nanotechnology-Asia Medicinal Plants from Peru: A Review of Plants as Potential Agents Against Cancer
Anti-Cancer Agents in Medicinal Chemistry Preventive and Therapeutic Role of Muscle Contraction Against Chronic Diseases
Current Pharmaceutical Design Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design Current and Future Drugs for Appetite Regulation and Obesity Treatment
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Templates and Models of Monoamine Transporter Proteins
Current Medicinal Chemistry Identifying the Predictors of Self-Management Behaviors in Patients with Diabetes Based on Ecological Approach: A Systematic Review
Current Diabetes Reviews Global HIV Prevention, Testing, and Counseling in Military Populations
Current HIV Research Rediscovering Tocophersolan: A Renaissance for Nano-Based Drug Delivery and Nanotheranostic Applications
Current Drug Targets Metabolomics of Medicinal Plants: The Importance of Multivariate Analysis of Analytical Chemistry Data
Current Computer-Aided Drug Design Antidepressants Alter Mesostriatal Dopamine Interactions with Serotonin Signaling
Current Psychiatry Reviews Metabolic and Amino Acid Alterations of the Tumor Microenvironment
Current Medicinal Chemistry ATP-Binding Cassette Transporters in Inflammatory Brain Disease
Current Pharmaceutical Design Pathogenesis of Type 1 Diabetes: Regulation of Adhesion Molecules and Immune Cell Trafficking
Current Immunology Reviews (Discontinued)